Synapse - Works

Results (4640)

Low objective response and high toxicity to single-agent mitotane in patients with metastatic adrenocortical carcinoma (ACC): A 25 year experience at MSKCC

Meeting Abstract

Lung, B. Y.; Valentino, E.; Gerst, S. R.; Untch, B. R.; Katz, S.; Strong, V. E.; Raj, N. P.; Olino, K.; Saltz, L.; Reidy, D. L.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC)

Meeting Abstract

Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Salehi, E.; Hollywood, E.; Bradley, M.; Sophos, N. A.; Ly, M.; Capanu, M.; Gerst, S. R.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

A phase III randomized double-blind study of prophylactic topical dapsone 5% versus moisturizer for cetuximab-induced papulopustular (acneiform) rash

Meeting Abstract

Lacouture, M. E.; Belum, V. R.; Kehn, D.; Cercek, A.; Kemeny, N. E.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211)

Meeting Abstract

Kunz, P. L.; Catalano, P. J.; Nimeiri, H. S.; Fisher, G. A.; Longacre, T. A.; Schrijver, I.; Reidy, D. L.; Strosberg, J. R.; O'Dwyer, P. J.; Benson, A.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Assessing the performance of Watson for oncology, a decision support system, using actual contemporary clinical cases

Meeting Abstract

Kris, M. G.; Gucalp, A.; Epstein, A. S.; Seidman, A. D.; Fu, J.; Keesing, J.; Caroline, A.; Megerian, M.; Eggebraaten, T.; DeLima, R.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Changing chemotherapy (C) with concurrent radiation (RT) followed by surgery after sub-optimal FDG-PET response to induction chemotherapy improves outcomes in locally advanced (LA) esophageal adenocarcinoma (EA)

Meeting Abstract

Kriplani, A.; Janjigian, Y. Y.; Kelsen, D. P.; Rusch, V. W.; Bains, M. S.; Rizk, N. P.; Chou, J. F.; Capanu, M.; Wu, A. J. C.; Goodman, K. A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Improvement in long-term survival in patients with metastatic colorectal cancer (CRC) after liver resection with modern chemotherapy and hepatic arterial infusion (HAI)

Meeting Abstract

Kemeny, N. E.; Chou, J. F.; Boucher, T. M.; Capanu, M.; DeMatteo, R. P.; Jarnagin, W. R.; Kingham, T. P.; Allen, P. J.; Fong, Y.; Cercek, A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase II study of FOLFOX plus regorafenib (REGO) in patients with unresectable or metastatic esophagogastric (EG) cancer

Meeting Abstract

Janjigian, Y. Y.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Siebel, M.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; Kelsen, D. P.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Dose escalation stage of a first-in-class phase I study of the novel oral ERK 1/2 kinase inhibitor BVD-523 (ulixertinib) in patients with advanced solid tumors

Meeting Abstract

Infante, J. R.; Janku, F.; Tolcher, A. W.; Patel, M. R.; Sullivan, R. J.; Flaherty, K.; Carvajal, R. D.; Varghese, A. M.; Wong, D. J. L.; Sznol, M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Multicenter prospective phase II trial of bevacizumab (bev) for progressive pancreatic neuroendocrine tumor (PNET)

Meeting Abstract

Hobday, T. J.; Yin, J.; Pettinger, A.; Strosberg, J. R.; Reidy, D. L.; Chen, H. X.; Erlichman, C.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save